Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Edmondson

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate)Dooseop Kim, Jennifer E Kowalchick, Scott D Edmondson, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2020
Novel potent and selective pyrazolylpyrimidine-based SYK inhibitorsBernard Barlaam, Scott Boiko, Scott Boyd, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2020
Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulantsZahid Hussain, Andrew J Cooke, Santhosh Neelamkavil, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitorsJinyou Xu, Lan Wei, Robert Mathvink, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2015
Discovery of benzamides as potent human β3 adrenergic receptor agonistsCheng Zhu, Nam F Kar, Bing Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
Discovery of potent and selective orally bioavailable beta-substituted phenylalanine derived dipeptidyl peptidase IV inhibitorsScott D Edmondson, Anthony Mastracchio, Joseph L Duffy, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Potent and selective proline derived dipeptidyl peptidase IV inhibitorsScott D Edmondson, Anthony Mastracchio, Maria Beconi, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2008
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesityRichard Berger, Cheng Zhu, Alexa R Hansen, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitorsScott D Edmondson, Anthony Mastracchio, Jason M Cox, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate)Dooseop Kim, Jennifer E Kowalchick, Scott D Edmondson, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2020
Novel potent and selective pyrazolylpyrimidine-based SYK inhibitorsBernard Barlaam, Scott Boiko, Scott Boyd, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2020
Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulantsZahid Hussain, Andrew J Cooke, Santhosh Neelamkavil, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitorsJinyou Xu, Lan Wei, Robert Mathvink, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2015
Discovery of benzamides as potent human β3 adrenergic receptor agonistsCheng Zhu, Nam F Kar, Bing Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
Discovery of potent and selective orally bioavailable beta-substituted phenylalanine derived dipeptidyl peptidase IV inhibitorsScott D Edmondson, Anthony Mastracchio, Joseph L Duffy, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Potent and selective proline derived dipeptidyl peptidase IV inhibitorsScott D Edmondson, Anthony Mastracchio, Maria Beconi, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2008
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesityRichard Berger, Cheng Zhu, Alexa R Hansen, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitorsScott D Edmondson, Anthony Mastracchio, Jason M Cox, et al.
Pageof 5